David Goertsen

Company: Capsida Biotherapeutics

Job title: Senior Scientist

Seminars:

Updates on Capsida’s Next-Generation Engineered AAV Capsids for the Clinic 2:15 pm

Platform advancements leading to breakthrough, IV-delivered engineered AAV capsids for the CNS Generations of directed evolution yields highly targeted AAV capsids with increased therapeutic index Potential for Capsida’s engineered AAVs to treat neurological disorders across all age groupsRead more

day: Conference Day Two